JPWO2024024865A1 - - Google Patents

Info

Publication number
JPWO2024024865A1
JPWO2024024865A1 JP2024537209A JP2024537209A JPWO2024024865A1 JP WO2024024865 A1 JPWO2024024865 A1 JP WO2024024865A1 JP 2024537209 A JP2024537209 A JP 2024537209A JP 2024537209 A JP2024537209 A JP 2024537209A JP WO2024024865 A1 JPWO2024024865 A1 JP WO2024024865A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024537209A
Other languages
Japanese (ja)
Other versions
JPWO2024024865A5 (enrdf_load_stackoverflow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2024024865A1 publication Critical patent/JPWO2024024865A1/ja
Publication of JPWO2024024865A5 publication Critical patent/JPWO2024024865A5/ja
Priority to JP2025084015A priority Critical patent/JP2025122084A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2024537209A 2022-07-28 2023-07-26 Pending JPWO2024024865A1 (enrdf_load_stackoverflow)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025084015A JP2025122084A (ja) 2022-07-28 2025-05-20 レボドパ持続性製剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022120247 2022-07-28
PCT/JP2023/027466 WO2024024865A1 (ja) 2022-07-28 2023-07-26 レボドパ持続性製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025084015A Division JP2025122084A (ja) 2022-07-28 2025-05-20 レボドパ持続性製剤

Publications (2)

Publication Number Publication Date
JPWO2024024865A1 true JPWO2024024865A1 (enrdf_load_stackoverflow) 2024-02-01
JPWO2024024865A5 JPWO2024024865A5 (enrdf_load_stackoverflow) 2024-08-22

Family

ID=89706575

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024537209A Pending JPWO2024024865A1 (enrdf_load_stackoverflow) 2022-07-28 2023-07-26
JP2025084015A Pending JP2025122084A (ja) 2022-07-28 2025-05-20 レボドパ持続性製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025084015A Pending JP2025122084A (ja) 2022-07-28 2025-05-20 レボドパ持続性製剤

Country Status (2)

Country Link
JP (2) JPWO2024024865A1 (enrdf_load_stackoverflow)
WO (1) WO2024024865A1 (enrdf_load_stackoverflow)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005528430A (ja) * 2002-05-29 2005-09-22 インパックス ラボラトリーズ、 インコーポレイテッド 組合せ即時放出および制御放出レボドーパ／カルビドーパ剤型
JP2011518148A (ja) * 2008-04-18 2011-06-23 インテック ファーマ リミテッド カルビドパ／レボドパ胃内滞留性薬物供給
JP2012500221A (ja) * 2008-08-15 2012-01-05 ディポメド，インコーポレイティド Ｃｎｓ障害の処理及び予防のための胃保持性医薬組成物
JP2016532655A (ja) * 2013-10-07 2016-10-20 インパックス ラボラトリーズ、 インコーポレイテッドＩｍｐａｘ Ｌａｂｏｒａｔｏｒｉｅｓ， Ｉｎｃ． レボドパ及び／又はレボドパのエステルの粘膜付着性制御放出配合物、並びにその使用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005528430A (ja) * 2002-05-29 2005-09-22 インパックス ラボラトリーズ、 インコーポレイテッド 組合せ即時放出および制御放出レボドーパ／カルビドーパ剤型
JP2011518148A (ja) * 2008-04-18 2011-06-23 インテック ファーマ リミテッド カルビドパ／レボドパ胃内滞留性薬物供給
JP2012500221A (ja) * 2008-08-15 2012-01-05 ディポメド，インコーポレイティド Ｃｎｓ障害の処理及び予防のための胃保持性医薬組成物
JP2016532655A (ja) * 2013-10-07 2016-10-20 インパックス ラボラトリーズ、 インコーポレイテッドＩｍｐａｘ Ｌａｂｏｒａｔｏｒｉｅｓ， Ｉｎｃ． レボドパ及び／又はレボドパのエステルの粘膜付着性制御放出配合物、並びにその使用

Also Published As

Publication number Publication date
JP2025122084A (ja) 2025-08-20
WO2024024865A1 (ja) 2024-02-01

Similar Documents

Publication Publication Date Title
BR202022009269U2 (enrdf_load_stackoverflow)
BR202022001779U2 (enrdf_load_stackoverflow)
BY13167U (enrdf_load_stackoverflow)
BY13169U (enrdf_load_stackoverflow)
CN307049114S (enrdf_load_stackoverflow)
CN307048994S (enrdf_load_stackoverflow)
CN307048906S (enrdf_load_stackoverflow)
CN307048389S (enrdf_load_stackoverflow)
CN307047959S (enrdf_load_stackoverflow)
CN307047552S (enrdf_load_stackoverflow)
CN307047460S (enrdf_load_stackoverflow)
CN307047422S (enrdf_load_stackoverflow)
CN307047310S (enrdf_load_stackoverflow)
CN307047191S (enrdf_load_stackoverflow)
CN307046922S (enrdf_load_stackoverflow)
CN307045948S (enrdf_load_stackoverflow)
CN307045727S (enrdf_load_stackoverflow)
CN307044996S (enrdf_load_stackoverflow)
CN307044988S (enrdf_load_stackoverflow)
CN307044921S (enrdf_load_stackoverflow)
BY13173U (enrdf_load_stackoverflow)
BY13172U (enrdf_load_stackoverflow)
BY13171U (enrdf_load_stackoverflow)
BY13170U (enrdf_load_stackoverflow)
BY13168U (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240702

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240702

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20240702

AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20240716

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240719

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241002

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241126

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250227

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250520

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20250520